Vimizim

Made by

• BioMarin Pharmaceutical Japan

Active Ingredient

Elosulfase alfa

Prospectus

Approval date

2014/12/26

Treats

• Mucopolysaccharidosis type IV

Dosages

• Vimizim Intravenous Infusion 5mg - 132314円／瓶